Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs

July 20, 2015 9:40 am | by University of Aberdeen | News | Comments

A crucial 'on switch' that boosts the body's defences against infections has been successfully identified in new scientific research. Read more...


DelMar Expands GBM Clinical Trial with 5th Site in Denver

July 20, 2015 9:34 am | News | Comments

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced that the Sarah Cannon Cancer Research Center at HealthOne, Denver, CO has been added as a clinical trial site for the ongoing, multicenter Phase I/II study of VAL-083 in patients with GBM. Read more...


Roche Expands HIV Global Access Program

July 20, 2015 9:30 am | News | Comments

Roche announced today an expansion to the HIV Global Access Program to include early infant HIV diagnostic testing for low and middle income countries. Read more...


Diabetes, Cardiovascular Link Often Overlooked

July 20, 2015 8:50 am | by University of Queensland | News | Comments

The program continues to support people in Australia with Type 1 and Type 2 diabetes. Read more...


Valeant Agrees to Acquire Amoun Pharmaceuticals

July 20, 2015 8:43 am | News | Comments

Valeant intends for Amoun to serve as a platform for further expansion in the broader Middle East and North Africa pharmaceutical market and expects the transaction to close in the third quarter. Read more...


Liberia Says 4 Remaining Ebola Patients Have Recovered

July 20, 2015 8:38 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

The four remaining patients infected during Liberia's recent string of Ebola cases have recovered, meaning there are currently no confirmed cases in the country though more than 100 people are still under surveillance, a health official said Friday. Read more...


Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 17, 2015 12:23 pm | News | Comments

Hospira, Inc. the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced it had obtained U.S. Food and Drug Administration (FDA) approval for the launch of bivalirudin for injection, a generic version of The Medicines Company's Angiomax. Read more...


Stem Cells Move One Step Closer to Cure for Genetic Diseases

July 17, 2015 12:20 pm | by Salk University | News | Comments

Healthy brain, muscle, eye and heart cells would improve the lives of tens of thousands of people around the world with debilitating mitochondrial diseases. Now, researchers at the Salk Institute have gotten one step closer to making such cures a reality: they’ve turned cells from patients into healthy, mutation-free stem cells that can then become any cell type. Read more...


Protein May Help Suppress Cancer Fades As We Age

July 17, 2015 12:12 pm | by UCLA | News | Comments

Researchers at UCLA have found that a protein that serves as a suppressor of cancer diminishes in skin and mouth epithelial cells as the human body ages. Read more...


Drug Discovery Spotlight: Studies Support Broader Statin Use; HCV Meds Cost-Effective

July 17, 2015 11:58 am | by Stephanie Guzowski, Editor | News | Comments

Two years ago, cardiology organizations issued guidelines, recommending use of a tool to assess patients’ risk of heart attack or stroke. The new method came under scrutiny, but this week, two published studies supported the cholesterol guidelines, which lead to wider statin use. Read about this news and more.


FDA Bans Founder of Fake U.S. Pharma Company Worth $12M

July 17, 2015 10:49 am | by Ryan Bushey, Associate Editor | News | Comments

The agency's ruling prevents the founder from providing any form of service to a person or company working on an approved or pending drug product application. Read more...


'Mini Bile Ducts' Identify Drugs that Could Prevent Liver Transplantation

July 17, 2015 9:36 am | by University of Cambridge | News | Comments

An experimental cystic fibrosis drug has been shown to prevent the disease’s damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab. Read more...


CDC: Lyme Disease Spread 320 Percent in 19 Years

July 17, 2015 9:28 am | by Seth Augenstein, Digital Reporter | News | Comments

Lyme disease continues to spread outward from two major clusters within the United States – areas of spread gradually enveloping new parts of the country, according to the Centers for Disease Control and Prevention. Read more...


First Made-In-Singapore Cancer Drug Enters Clinical Testing

July 17, 2015 9:22 am | by Biomedical Sciences Institute | News | Comments

A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the live of cancer patients in Singapore, and worldwide. Read more...


Improving Treatment for Systemic Amyloidosis

July 17, 2015 8:28 am | by University College London | News | Comments

A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.